You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CYB003-001

Showing 51 - 75 of 3,080
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cataract Trial in United States (CVisc50 OVD, ProVisc OVD)

Completed
  • Cataract
  • CVisc50 OVD
  • +2 more
  • Chandler, Arizona
  • +21 more
Dec 13, 2022

Hyperkalemia, Renal Insufficiency, Chronic Trial in China (Patiromer Powder for Oral Suspension (Part A), Placebo (Part B),

Recruiting
  • Hyperkalemia
  • Renal Insufficiency, Chronic
  • Patiromer Powder for Oral Suspension (Part A)
  • +2 more
  • Hefei, Anhui, China
  • +21 more
Sep 15, 2022

Myopia Trial in Worldwide (NVK-002 Concentration 1, NVK-002 Concentration 2, Placebo)

Active, not recruiting
  • Myopia
  • NVK-002 Concentration 1
  • +2 more
  • Tucson, Arizona
  • +25 more
Jan 3, 2023

Partial Seizures Trial in Japan (Levetiracetam)

Active, not recruiting
  • Partial Seizures
  • Fukuoka, Japan
  • +20 more
Mar 10, 2022

Depressive Symptoms, Parkinson's Disease Trial in Italy (Rasagiline, Placebo)

Completed
  • Depressive Symptoms
  • Parkinson's Disease
  • Cagliari, Italy
  • +11 more
Aug 30, 2021

Breast Cancer Trial in Japan, Korea, Republic of, Taiwan (Tucatinib, Trastuzumab, Capecitabine)

Active, not recruiting
  • Breast Cancer
  • Nagoya, Aichi, Japan
  • +27 more
Nov 30, 2022

Actinic Keratoses Trial in United States (Test Product (A): Fluorouracil Cream, 5% topical cream, Reference Product (B):

Recruiting
  • Actinic Keratoses
  • Test Product (A): Fluorouracil Cream, 5% topical cream
  • +2 more
  • Bakersfield, California
  • +6 more
Apr 22, 2022

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Heterozygous Familial Hypercholesterolemia, Elevated Cholesterol Trial in Worldwide (Inclisiran, Placebo)

Completed
Has Results
  • Heterozygous Familial Hypercholesterolemia
  • Elevated Cholesterol
  • Mission Viejo, California
  • +44 more
Oct 6, 2020

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial in Japan (epcoritamab

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • epcoritamab (monotherapy)
  • +5 more
  • Chuo Ku, Japan
  • +19 more
Nov 22, 2022

SARS-CoV-2 Infection, COVID-19 Trial in South Africa (SARS-CoV-2 rS/Matrix-M1 Adjuvant, Placebo)

Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • SARS-CoV-2 rS/Matrix-M1 Adjuvant
  • Placebo
  • Bloemfontein, Free State Of South Africa, South Africa
  • +13 more
Feb 14, 2022

Generalized Anxiety Disorder Trial in Decatur (CYB004, Psychotherapy)

Not yet recruiting
  • Generalized Anxiety Disorder
  • Decatur, Georgia
    iResearch Atlanta
Sep 20, 2023

Idiopathic Pulmonary Fibrosis, Pulmonary Disease, Pulmonary Medicine Trial in France (Blood sample)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • +2 more
  • Blood sample
  • Bobigny, Avicenne, France
  • +15 more
Oct 22, 2021

Ulcerative Colitis Trial in United States (Low Dose MT-1303, High Dose MT-1303, Placebo)

Recruiting
  • Ulcerative Colitis
  • Low Dose MT-1303
  • +2 more
  • Chandler, Arizona
  • +22 more
Jun 7, 2022

Coronary Stenosis Trial in Worldwide (SUPRAFLEX, XIENCE)

Completed
  • Coronary Stenosis
  • SUPRAFLEX
  • XIENCE
  • Plovdiv, Bulgaria
  • +22 more
Dec 16, 2020

NonSegmental Vitiligo Trial in Canada, United States (INCB054707, Placebo)

Active, not recruiting
  • NonSegmental Vitiligo
  • Hoover, Alabama
  • +30 more
Nov 14, 2022

Irritable Bowel Syndrome Trial in Fayetteville (MHNA-001)

Active, not recruiting
  • Irritable Bowel Syndrome
  • MHNA-001
  • Fayetteville, North Carolina
    Carolina Institute for Clinical Research
Jan 23, 2023

Safety and Tolerability Trial in Glendale (Experimental drug: ESK-001, Placebo)

Recruiting
  • Safety and Tolerability
  • Experimental drug: ESK-001
  • Placebo
  • Glendale, California
    Alumis Central site
Jun 20, 2022

Prevention of Herpes Zoster (HZ) Trial in Herston (Treatment 1 (EG-HZ-001), Treatment 2 (EG-HZ-002), Treatment 3 (EG-HZ-003))

Completed
  • Prevention of Herpes Zoster (HZ)
  • Treatment 1 (EG-HZ-001)
  • +4 more
  • Herston, Queensland, Australia
    Q-Pharm Pty Ltd (Nucleus Network)
Feb 3, 2021

Moderate to Severe Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis Trial in Japan (Placebo, Certolizumab

Completed
Has Results
  • Moderate to Severe Psoriasis
  • Generalized Pustular Psoriasis and Erythrodermic Psoriasis
  • Placebo
  • Certolizumab Pegol
  • Asahikawa, Japan
  • +32 more
Dec 13, 2021

Triple-Negative Breast Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Nab-paclitaxel)

Active, not recruiting
  • Triple-Negative Breast Cancer
  • Birmingham, Alabama
  • +23 more
Jan 19, 2023

COPD (COPD) Trial in Worldwide (CHF5259 or Placebo administration)

Completed
  • Chronic Obstructive Pulmonary Disease (COPD)
  • CHF5259 or Placebo administration
  • Karlovy Vary, Czechia
  • +29 more
Jul 30, 2020

Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
Jan 20, 2023

Safety, Tolerability, Pharmacokinetics Trial in Karachi (RHN-001 (one tablet 750mg), RHN-001 (750mg * 2 Tablets))

Completed
  • Safety
  • +2 more
  • RHN-001 (one tablet 750mg)
  • RHN-001 (750mg * 2 Tablets)
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research (CBSCR),
Apr 26, 2023

Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%

Not yet recruiting
  • Acneiform Eruption Due to Chemical
  • +2 more
  • HT-001 2% Topical Gel
  • +3 more
  • (no location specified)
Dec 3, 2022